Mad1 expression in the absence of differentiation: Effect of cAMP on the B-lymphoid cell line Reh

Journal of Cellular Physiology

Volumn 178, Issue 1, 1999, Pages 76-84

  Naderi, Soheil ^a,b   Blomhoff, Heidi Kiil ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD34 ANTIGEN; CD37 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIC AMP; FORSKOLIN; MEMBRANE PROTEIN; PROTEIN MAD1; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CYCLIC AMP; DNA-BINDING PROTEINS; FORSKOLIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HELIX-LOOP-HELIX MOTIFS; HUMANS; LEUKEMIA, B-CELL; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; RNA, MESSENGER; STEM CELLS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 3743155137     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199901)178:1<76::AID-JCP10>3.0.CO;2-2     Document Type: Article

References (62)

1. Amati B, Dalton S, Brooks MW, Littlewood TD, Evan GI, Land H. 1992. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 359:423-426.
2. Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI, Land H. 1993a. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 72:233-245.
3. Amati B, Littlewood TD, Evan GI, Land H 1993b. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J 12:5083-5087.
4. Amin C, Wagner AJ, Hay N. 1993. Sequence-specific transcriptional activation by Myc and repression by Max. Mol Cell Biol 13:383-390.
5. Andersson KB, Deggerdal A, Skjønsberg C, Smeland EB, Blomhoff HK. 1993. Constitutive expression of c-myc does not relieve cAMP-mediated growth arrest in human lymphoid Reh cells. J Cell Physiol 157:61-69.
6. Ayer DE, Eisenman RN. 1993. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev 7:2110-2119.
7. Ayer DE, Kretzner L, Eisenman RN. 1993. Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72:211-222.
8. Berberich S, Hyde-DeRuyescher N, Espenshade P, Cole M. 1992. max encodes a sequence-specific DNA-binding protein and is not regulated by serum growth factors. Oncogene 7:775-779.
9. Blackwell TK, Huang J, Ma A, Kretzner L, Alt FW, Eisenman RN, Weintraub H. 1993. Binding of Myc proteins to canonical and non-canonical DNA sequences. Mol Cell Biol 13:5216-5224.
10. Blackwood EM, Eisenman RN. 1991. Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211-1217.
11. Blackwood EM, Lüscher B, Eisenman RN. 1992. Myc and Max associate in vivo. Genes Dev 6:71-80.
12. Blomhoff HK, Smeland EB, Beiske K, Blomhoff R, Ruud E, Bjøro T, Pfeiffer-Ohlsson S, Watt R, Funderud S, Godal T, Ohlsson R. 1987. Cyclic AMP-mediated suppression of normal and neoplastic B-cell proliferation is associated with regulation of myc and Ha-ras protooncogenes. J Cell Physiol 131:426-433.
13. Cerni C, Bousset K, Seelos C, Burkhardt H, Henriksson M, Lüscher B. 1995. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. Oncogene 11:587-596.
14. Chen J, Willingham T, Margraf LR, Schreiber-Agus N, DePinho RA, Nisen PD. 1995. Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumor cells. Nature Med 1:638-643.
15. Chin L, Schreiber-Agus N, Pellicer I, Chen K, Lee H-W, Dudast M, Cordon-Cardo C, DePinho RA. 1995. Contrasting roles for Myc and Mad proteins in cellular growth and differentiation. Proc Natl Acad Sci U S A 92:8488-8492.
16. Christoffersen J, Smeland EB, Stokke T, Tasken K, Andersson KB, Blomhoff HK. 1994. Retinoblastoma protein is rapidly dephosphorylated by elevated cyclin adenosine monophosphate levels in human B-lymphoid cells. Cancer Res 54:2245-2250.
17. Coffey RJ, Bascom CC, Sipes NJ, Graves-Deal R, Weissman BE, Moses HL. 1988. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor β. Mol Cell Biol 8:3088-3093.
18. Coppola JA, Cole MD. 1986 Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment. Nature 320:760-763.
19. Cultraro CM, Bino T, Segal S. 1997. Function of the c-Myc antagonist during a molecular switch from proliferation to differentiation. Mol Cell Biol 17:2353-2359.
20. Dalla-Favera R, Gelmann EP, Martinotti S, Frachini G, Papas TS, Gallo RC, Wong-Staal F. 1982. Cloning and characterization of different human sequences related to the one gene (v-myc) of avian myelocytomatosis virus (MC29). Proc Natl Acad Sci U S A 79:6497-6501.
21. Dean M, Levine KA, Ran W, Kindy MS, Sonenshein GE, Campisi J. 1986. Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact. J Biol Chem 261:9161-9166.
22. Dmitrovsky E, Kuehl WM, Hollis GF, Kirsch IR, Bender TP, Segal S. 1986. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line. Nature 322: 748-750.
23. Eckhardt SG, Dai A, Davidson KK, Forseth BJ, Wahl GM, Von Hoff DD. 1994. Induction of differentiation in HL60 cells by the reduction of extrachromosomally amplified c-myc. Proc Natl Acad Sci U S A 91:6674-6678.
24. 1. Mol Cell Biol 8:1614-1624.
25. Galaktionov K, Chen X, Beach D. 1996. Cdc25 cell cycle phosphatase as a target of c-myc. Nature 382:511-517.
26. Grana X, Reddy P. 1995. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11:211-219.
27. Gu W, Cechova K, Tassi V, Dalla-Favera R. 1993. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Proc Natl Acad Sci U S A 90:2935-2939.
28. Hamel PA, Gill RM, Philips RA, Gallie BL. 1992. Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol Cell Biol 12:3431-3438.
29. Heinzel T, Lavinski RM, Mullen TM, Söderström M, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG. 1997. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43-38.
30. Henriksson M, Lüscher B. 1996. Proteins of the Myc-network: essential regulators of cell growth and differentiation. Adv Cancer Res 68:109-182.
31. Hoffman-Liebermann B, Liebermann DA. 1991. Interleukin-6-and leukemia inhibitory factor-induced terminal differentiation of myeloid leukemia cells is blocked at an intermediate stage by constitutive c-myc. Mol Cell Biol 11:2375-2381.
32. Holt JT, Redner RL, Nienhuis AW. 1988. An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol Cell Biol 8:963-973.
33. Hurlin PJ, Ayer DE, Grandori C, Eisenman RN. 1994. The Max transcription factor network: Involvement of Mad in differentiation and an approach to identification of target genes. Cold Spring Harb Symp Quant Biol 59:109-116.
34. Hurlin PJ, Foley KP, Ayer DE, Eisenman RN, Hanahan D, Arbeit JM. 1995a. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. Oncogene 11:2487-2501.
35. Hurlin PJ, Quéva C, Koskinen PJ, Steingrimsson E, Ayer DE, Copeland NG, Jenkins NA, Eisenman RN. 1995b. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-Myc-dependent transformation and are expressed during neural and epidermal differentiation. EMBO J 14:5646-5659.
36. Koskinen PJ, Ayer DE, Eisenman RN. 1995. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions. Cell Growth Differ 6:623-629.
37. Kretzner L, Blackwood EM, Eisenman RN. 1992. Myc and Max proteins possess distinct transcriptional activities. Nature 310:426-429.
38. Lachman HM, Skoultchi AI. 1984. Expression of c-myc changes during differentiation of mouse erythroleukaemia cells. Nature 310: 592-594.
39. Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, Eisenman RN. 1997. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89:349-356.
40. Lahoz EG, Xu L, Schreiber-Agus N, DePinho RA. 1994. Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. Proc Natl Acad Sci U S A 91:5503-5507.
41. Larsson L-G, Pettersson M, Öberg F, Nilsson K, Lüscher B. 1994. Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Onocogene 9:1247-1252.
42. Larsson L-G, Bahram F, Burkhardt H, Lüscher B. 1997. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarsinoma cells. Oncogene 15:737-748.
43. Lindmo T, Aarnaes E. 1979. Selection of optimal model for the DNA histogram by analysis of error of estimated parameters. J Histochem Cytochem 27:297-304.
44. 1 arrest in B-lymphoid cell lines. Exp Cell Res 172:84-91.
45. Lüscher B, Eisenman RN. 1990. New light on Myc and Myb. Part I. Myc. Genes Dev 4:2025-2035.
46. Lüscher B, Kuenzel EG, Krebs EG, Eisenman RN. 1989. Myc oncoproteins are phosphorylated by casein kinase II. EMBO J 8:1111-1119.
47. Lymboussaki A, Kaipainen A, Hatva E, Vastrik I, Jeskanen L, Jalkanen M, Werner S, Stenback F, Alitalo R. 1996. Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin. Br J Cancer 73: 1347-1355.
48. Marcu KB, Bossone SA, Patel AJ. 1992. myc function and regulation. Annu Rev Biochem 61:809-860.
49. Maruyama K, Schiavi SC, Huse W, Johnson GL, Ruley HE. 1987. myc and E1A oncogenes alter the responses of PC12 cells to nerve growth factor and block differentiation. Oncogene 1:361-367.
50. Miner JH, Wold BJ. 1991. c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation. Mol Cell Biol 11:2842-2851.
51. Mukherjee B, Morgenbesser SD, DePinho RA. 1992. Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants. Genes Dev 6:1480-1492.
52. Nagy L, Kao H-Y, Chakravarti D, Lin RJ, Hassig CH, Ayer DE, Schreiber SL, Evans RM. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373-380.
53. Prendergast GC, Lawe D, Ziff EB. 1991. Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras cotransformation. Cell 65:395-407.
54. Reitsma PH, Rothberg PG, Astrin SM, Trial J, Bar-Shavit Z, Hall A, Teitelbaum SL, Kahn AJ. 1983. Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite. Nature 306: 492-494.
55. Rosenfeld C, Goutner A, Choquet C, Venuat AM, Kayibanda B, Pico JL, Greaves MF. 1977. Phenotypic characterization of a unique non-T, non-B, acute lymphoblastic leukaemia cell line. Nature 267: 841-843.
56. Roussel MF, Ashmun RA, Sherr CJ, Eisenman RN, Ayer DE. 1996. Inhibition of cell proliferation by the Mad1 transcriptional repressor. Mol Cell Biol 16:2796-2801.
57. Skjønsberg C, Erikstein BK, Smeland EB, Lie SO, Funderud S, Beiske K. Blomhoff HK. 1991. Interleukin-7 differentiates a subgroup of acute lymphoblastic leukemias. Blood 77:2445-2450.
58. Stokke T, Holte H, Steen HB. 1988. In vitro and in vivo activation of B-lymphocytes: a flow cytometric study of chromatin structure employing 7-aminoactinomycin D. Cancer Res 48:6708-6714.
59. Västrik I, Kaipainen A, Penttilä T-L, Lymboussakis A, Alitalo R, Parvinen M, Alitalo K. 1995. Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro. J Cell Biol 128:1197-1208.
60. Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
61. Westin EH, Wong-Staal F, Gelmann EP, Dalla-Favera R, Papas TS, Lautenberger JA, Eva A, Reddy EP, Tronick SR, Aaronson SA, Gallo RC. 1982. Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. Proc Natl Acad Sci U S A 79:2490-2494.
62. Zervos AS, Gyuris J, Brent R. 1993. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72:223-232.